Vijaya Diagnostic Centre Limited has made available the audio recording of its earnings conference call for the first quarter of fiscal year 2027 (Q1FY27). The call was organized on August 07, 2026, following the declaration of the company’s unaudited financial results for the quarter and the year ended March 31, 2026. This disclosure ensures transparency and provides stakeholders with direct access to management’s commentary on the recent financial performance.

The audio recording is accessible via a dedicated link provided in the company’s communication to the National Stock Exchange of India Limited (NSE) and BSE Limited. Additionally, the recording is hosted on the company’s official website under the Investors section, specifically within the Financial Results tab for FY 2026-27. This move aligns with regulatory requirements for timely dissemination of material information to investors.

Earnings Call Details

The conference call took place on August 07, 2026, allowing investors and analysts to engage with management regarding the Q1FY27 results. The session covered key financial metrics, operational highlights, and strategic initiatives discussed during the quarter. The availability of the audio recording enables those who could not attend live to review the discussions at their convenience.

Regulatory Compliance

Vijaya Diagnostic Centre Limited submitted the link to the earnings call audio to the Listing Department of NSE and the Corporate Relations Department of BSE. The submission was signed by Naga Vasudha Tadepalli, Company Secretary & Compliance Officer, affirming compliance with SEBI regulations. The company emphasized that the recording is also available on its website for broader investor access.

What This Means for Investors

The release of the earnings call audio provides an additional layer of insight into the company’s performance beyond the numerical data presented in the financial statements. Investors can gain context on management’s perspective on growth drivers, such as volume surge and new hub commissions, as well as future outlooks. This transparency supports informed decision-making for shareholders and potential investors.

Vijaya Diagnostic Centre has finalized the distribution of proceeds from the sale of fractional entitlements generated during its scheme of amalgamation with Medinova Diagnostic Services Limited. The company’s Audit Committee and Independent Directors certified on August 6, 2026, that net sale proceeds totaling ₹51,84,902.83 have been disbursed to eligible shareholders or held in escrow in compliance with Securities and Exchange Board of India (SEBI) regulations.

The certification addresses the resolution of fractional shares that emerged from the 22:1 share exchange ratio approved by the National Company Law Tribunal (NCLT), Hyderabad Bench. Under the scheme, Medinova shareholders received one Vijaya Diagnostic Centre equity share for every 22 Medinova shares held as of the record date on November 25, 2025. Allotments were issued on January 8, 2026. Fractional entitlements aggregating to 3,914 equity shares were consolidated and allotted to Catalyst Trusteeship Limited, the corporate trustee appointed by the Board, to hold in trust for eligible shareholders.

Vijaya Diagnostic Centre sold the 3,914 fractional shares on June 22, 2026, generating gross proceeds of ₹51,97,897.68 at an average price of ₹1,328.027 per share. After deducting expenses and applicable taxes amounting to ₹12,994.85, the net sale proceeds stood at ₹51,84,902.83. These funds were transferred to a separate account with HDFC Bank titled "Vijaya Diagnostic Centre Ltd-Fractional shares" specifically for distribution purposes.

Distribution was executed via banking mode on August 5, 2026. However, a significant portion of the funds could not be immediately disbursed due to incomplete or unavailable bank account details for certain eligible shareholders. Consequently, ₹36,85,326.84 has been maintained in an escrow account (account number 50200118300305) with HDFC Bank. Only ₹14,99,575.99 was directly credited to shareholders who provided valid banking information.

The company has undertaken to use its best efforts to trace the missing bank details and remit the outstanding amounts. If the details remain untraceable after seven years despite these efforts, the unpaid amounts will be transferred to the Investor Education and Protection Fund (IEPF) as per statutory rules. This process ensures compliance with Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023, which mandates the disposal of fractional entitlements and proportional distribution of proceeds to shareholders.